AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 216 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $346,000 | +19.3% | 6,700 | 0.0% | 0.00% | – |
| Q4 2020 | $290,000 | +23.4% | 6,700 | 0.0% | 0.00% | – |
| Q3 2020 | $235,000 | -36.3% | 6,700 | -2.9% | 0.00% | – |
| Q2 2020 | $369,000 | +48.8% | 6,900 | -1.4% | 0.00% | – |
| Q1 2020 | $248,000 | +12.7% | 7,000 | +52.2% | 0.00% | – |
| Q4 2019 | $220,000 | +47.7% | 4,600 | 0.0% | 0.00% | – |
| Q3 2019 | $149,000 | -97.2% | 4,600 | -95.7% | 0.00% | -100.0% |
| Q2 2019 | $5,344,000 | -44.6% | 107,134 | -25.1% | 0.00% | -71.4% |
| Q1 2019 | $9,648,000 | +4899.0% | 143,050 | +3306.0% | 0.01% | – |
| Q4 2018 | $193,000 | -73.4% | 4,200 | -55.3% | 0.00% | -100.0% |
| Q3 2018 | $725,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |